Panacea Biotec Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Panacea Biotec Ltd with three other
companies in this sector in INDIA :
Bajaj Healthcare Ltd
sales of 6.57 billion Indian Rupees [US$87.64 million]
of which 90%
was Bulk Drugs),
Bliss GVS Pharma Limited
(5.77 billion Indian Rupees [US$77.00 million]
of which 100%
was Pharmaceuticals), and
Venus Remedies Ltd
(5.48 billion Indian Rupees [US$73.12 million]
During the first
quarter of 2022, sales at Panacea Biotec Ltd totalled
1.32 billion Indian Rupees .
practically unchanged from the previous year, and is only
an increase of 0.7%
from the 1.31 billion Indian Rupees in sales at the company during the first quarter of 2021.
Panacea Biotec Ltd reported sales of 6.20 billion Indian Rupees (US$82.76 million)
March of 2021.
increase of 15.1%
versus 2020, when the company's sales were 5.39 billion Indian Rupees .
The sales level in 2021 was fairly close to the level five years ago: in 2016, Panacea Biotec Ltd had sales
of 6.53 billion Indian Rupees .
Sales of Vaccine saw an increase
that was more than double the company's growth rate: sales were up
71.5% in 2021, from
1.33 billion Indian Rupees to 2.28 billion Indian Rupees .
Not all segments of Panacea Biotec Ltd experienced an increase in sales in 2021:
sales of Formulation fell 3.5% to 3.97 billion Indian Rupees .